Taner Demirer

Ankara University — Turkey

Medicine · Health Sciences

36h-index4.4kcitations182works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(84), Acute Myeloid Leukemia Research(23), Lymphoma Diagnosis and Treatment(22), Chronic Lymphocytic Leukemia Research(21), Multiple Myeloma Research and Treatments(18)

Publications182 total

Periferik T-Hücreli Lenfoma Hastalarının Geriye Dönük Değerlendirmesi: Tek Merkez Gerçek Yaşam Deneyimi
LLM Dergi·2025Open Access
Akut Miyeloid Lösemi Tanılı Fit Yaşlı Hastalarda Allojeneik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi
LLM Dergi·2025
RETRACTED: Are Generic Imatinib Formulations Really as Effective as Originial Imatinib in Chronic Myeloid Leukemia: Real Life Data
2025Open Access
Hodgkin Lenfomalı Hastalarda Tedavi Sonrası Geç Dönemde Yüksek Hematokrit Değerleri: Lenfoma ile Eritrositoz Arasında İlişki mi var?
LLM Dergi·2024Open Access
Anaplastic Multiple Myeloma: An Aggressive Myeloma Variant with A Poor Response to Autologous Stem Cell Transplantation
Journal of Ankara University Faculty of Medicine·2024Open Access
Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience
Blood·2023· 1 citedOpen Access
PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
HemaSphere·2023Open Access
P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES
HemaSphere·2023· 1 citedOpen Access
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
Balkan Medical Journal·2023Open Access
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
Balkan Medical Journal·2022· 10 citedOpen Access
RETRACTED: Are Generic Imatinib Formulations Really as Effective as Originial Imatinib in Chronic Myeloid Leukemia: Real Life Data
2022Open Access
The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes
Blood·2022
İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi
LLM Dergi·2022Open Access
The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.
Journal of Clinical Oncology·2022
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma & Leukemia·2022· 2 cited
Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease
Indian Journal of Hematology and Blood Transfusion·2022· 1 citedOpen Access
The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma
Blood·2021
The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis
Journal of Ankara University Faculty of Medicine·2021· 1 citedOpen Access
Brentuksimab Vedotin Treatment in Relaps Refractory Hodgkin Lymphoma: A Single Center Experience
LLM Dergi·2021Open Access
Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia
Experimental and Clinical Transplantation·2021
page 1 of 10Next →

Frequent Co-authors

CD Buckner(13), Jack W. Singer(12), Rainer Storb(11), Scott D. Rowley(10), K Lilleby(9), Günhan Gürman(7), Muhıt Özcan(7), Erden Atilla(6), C. Dean Buckner(6), Hamdi Akan(6), Ted Gooley(5), Pınar Ataca Atilla(5), A Fefer(5), Marco Bregni(5), Giovanni Rosti(5), Önder Arslan(5), Nahıde Konuk(5), Osman İlhan(5), FR Appelbaum(4), R Clift(4)